Delphi Diagnostics Inc. Company Profile, Contacts & Intelligence

Delphi Diagnostics Inc. Overview

Delphi Diagnostics Inc. is a Texas-based company focused on advancing clinically valid tests for the prognosis and prediction of breast cancer treatment. Delphi Diagnostics, Inc. holds an exclusive license from The University of Texas MD Anderson Cancer Center in Houston, TX to commercialize the Endocrine Activity Index, a technology that was developed by the laboratory of Dr. W. Fraser Symmans. The Endocrine Activity Index (EAI) test measures endocrine activity in stage II-III, HR+HER2- breast cancer. Delphi’s vision is to make the EAI test available to breast cancer patients and open new pathways for personalized breast cancer treatment.

Headquarters

Houston, Tx, United States

Website

www.delphi-diagnostics.com

Industry

Biotechnology Research

Founded

2016

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Delphi Diagnostics Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Delphi Diagnostics Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Delphi Diagnostics Inc. Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Delphi Diagnostics Inc.

Explore companies in related markets and compare their industry and employee estimates.